$ 25.14
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Excellent dividends
About
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair value on EV/E
Target Price
The average target price of PFE is 28 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
